Regeneron Pharmaceuticals (REGN) Share-based Compensation (2009 - 2026)
Regeneron Pharmaceuticals (REGN) posted Share-based Compensation of $243 million for Q2 2026, down 3.5% from $251.7 million a year earlier and down 5.6% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Share-based Compensation (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Regeneron Pharmaceuticals was $986.7 million, down 4.8% year-over-year; for FY2025, it came in at $993.7 million, up 1.1% from FY2024.
- Annual Share-based Compensation has increased for five consecutive years, with a five-year compound annual growth rate of 18.1% (FY2020 to FY2025).
- In prior years, Regeneron Pharmaceuticals' Share-based Compensation was $982.8 million in FY2024 (+11.1%), $885 million in FY2023 (+22.1%), $725 million in FY2022 (+20.5%) and $601.7 million in FY2021 (+39.3%).
- Quarterly Share-based Compensation has run from a low of $136.9 million in Q3 2021 to a high of $304.4 million in Q4 2024 over five years.
- On a year-over-year basis, Share-based Compensation increased in six of the last eight quarters, with growth averaging 5.7%.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q4 2021, with growth of 55.1%; the weakest was Q4 2025, with a decline of 18.1%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $257.4 million (Q1 2026), $249.3 million (Q4 2025) and $237 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 243.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 243.00 Mn |
| Mar 31, 2026 | 257.40 Mn |
| Dec 31, 2025 | 249.30 Mn |
| Sep 30, 2025 | 237.00 Mn |
| Jun 30, 2025 | 251.70 Mn |
| Mar 31, 2025 | 255.70 Mn |
| Dec 31, 2024 | 304.40 Mn |
| Sep 30, 2024 | 225.10 Mn |
| Jun 30, 2024 | 223.20 Mn |
| Mar 31, 2024 | 230.10 Mn |
| Dec 31, 2023 | 240.40 Mn |
| Sep 30, 2023 | 203.90 Mn |
| Jun 30, 2023 | 202.00 Mn |
| Mar 31, 2023 | 238.70 Mn |
| Dec 31, 2022 | 232.00 Mn |
| Sep 30, 2022 | 166.30 Mn |
| Jun 30, 2022 | 159.80 Mn |
| Mar 31, 2022 | 166.90 Mn |
| Dec 31, 2021 | 188.40 Mn |
| Sep 30, 2021 | 136.90 Mn |
API Access
Regeneron Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();